Oct 8, 2025, 11:08 AM by

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

Oct 8, 2025, 11:08 AM by

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Oct 8, 2025, 11:08 AM by

Oct 7, 2025, 08:23 AM by

Lonza has announced the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium to expand its GMP solutions for cell and gene therapy.

Oct 6, 2025, 09:29 AM by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Oct 3, 2025, 07:59 AM by

Oct 3, 2025, 07:59 AM by

Oct 3, 2025, 07:59 AM by

- Insilico published a new study unveiling Target Identification Pro (TargetPro), a superior disease-specific model, and TargetBench 1.0, the first standardized benchmarking framework for target discovery. - TargetPro achieved 71.6% retrieval of known clinical targets, a 2–3x improvement over large language models (LLMs) such as GPT-4o, Grok3, DeepSeek-R1, Claude-Opus-4, BioGPT, and public platforms like Open Targets. - TargetPro’s predicted novel targets demonstrated 95.7% structure availability, 86.5% druggability, and 46% repurposing potential, outperforming competing systems on all measures. - TargetBench’s explainable AI models revealed disease-specific feature importance patterns, emphasizing the value of disease-specific target identification models. - New gold standard approaches improve accuracy, reliability, and transparency in AI-driven drug discovery.

Oct 3, 2025, 07:59 AM by

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development.

Oct 2, 2025, 07:40 AM by

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

Oct 2, 2025, 01:01 AM by User Not Found

Bio-IT World | The Pistoia Alliance has launched a new initiative to advance the safe adoption of agentic AI. The initiative sits under the Alliance’s strategic priority to Harness AI to Expedite R&D and alongside its AI/ML Community of Experts, which is actively seeking further funding to continue supporting responsible AI adoption across the industry.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Quantabio has launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 08:40 AM by

Oct 1, 2025, 01:01 AM by User Not Found

Bio-IT World | Bio-IT World is now accepting entries for the 2026 Innovative Practices Awards, a competition designed to recognize the most exciting partnerships and projects pushing the life sciences industry forward. The deadline for entry is March 2, 2026, and the $300 application fee will be waived for entrants who meet the early submission deadline of January 30, 2026.

Sep 30, 2025, 08:47 AM by

Sep 30, 2025, 08:47 AM by